Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis. A new fracture-healing model at the tibia in rat
Authors:
Open Access
- 2 December 2008
- journal article
- research article
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 395 (2) , 163-172
Abstract
Background Fracture healing in osteoporosis is delayed. Quality and speed of fracture healing in osteoporotic fractures are crucial with regard to the outcome of patients. The question arises whether established antiosteoporotic drugs can further improve fracture healing. Materials and methods Osteoporosis manifests predominantly in the metaphyseal bone. Nevertheless, an established metaphyseal fracture model is lacking. A standardized metaphyseal fracture-healing model with stable plate fixation was developed for rat tibiae. The healing process was analyzed by biomechanical, gene expression, and histomorphometric methods in ovariectomized (OVX) and sham-operated rats (SHAM), compared to standardized estrogen (E)- and raloxifene (R)-supplemented diets. Results Estrogen and raloxifene improved the biomechanical properties of bone healing compared to OVX (Yield load: \({\text{SHAM}} = 63.1 \pm 20.8{\text{N}}\), \(\operatorname{E} = 60.8 \pm 17.9\operatorname{N} \), \(\operatorname{R} = 44.7 \pm 17.5\operatorname{N} \), \({\text{OVX}} = 32.5 \pm 22.0\operatorname{N} \)). Estrogen vs OVX was significant based on a denser trabecular network. Raloxifene greatly induced total callus formation (\(\operatorname{R} = 5.3 \pm 0.9\;{\text{mm}}^{\text{2}} \), \(\operatorname{E} = 4.7 \pm 0.5\;{\text{mm}}^{\text{2}} \), \({\text{SHAM}} = 4.51 \pm 0.61\;{\text{mm}}^{\text{2}} \),\({\text{OVX}} = 4.1 \pm 0.6\;{\text{mm}}^2 \)), whereas estrogen mainly enhanced new endosteal bone formation. There was no correlation between the gene expression (osteocalcin, collagen1α1, IGF-1, tartrate-resistant phosphatase) in the callus and the morphology and quality of callus formation. Conclusion Raloxifene and estrogen improve fracture healing in osteoporotic bone significantly with regard to callus formation, resistance, and elasticity. The biomechanically stable metaphyseal osteotomy model with T-plate fixation presented here has proven to be appropriate to investigate fracture healing in osteoporosis.
Keywords
This publication has 37 references indexed in Scilit:
- Combined effects of recombinant human BMP-7 (rhBMP-7) and parathyroid hormone (1–34) in metaphyseal bone healingBone, 2008
- Additive effects of PTH and bisphosphonates on the bone healing response to metaphyseal implants in ratsActa Orthopaedica, 2008
- Effects of OP‐1 and PTH in a new experimental model for the study of metaphyseal bone healingJournal of Orthopaedic Research, 2007
- Do serological tissue turnover markers represent callus formation during fracture healing?Bone, 2005
- Identification of estrogen-regulated genes during fracture healing, using DNA microarrayJournal of Bone and Mineral Metabolism, 2004
- Raloxifene, Estrogen, and Alendronate Affect the Processes of Fracture Repair Differently in Ovariectomized RatsJournal of Bone and Mineral Research, 2002
- Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-β1) from a biodegradable poly(d,l-lactide) coating of osteosynthetic implants accelerates fracture healing in ratsBone, 2001
- Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis FoundationJournal of Bone and Mineral Research, 1997
- Effect of 1alpha-vitamin D3 and estrogen therapy on cortical bone mechanical properties in the ovariectomized rat modelEndocrinology, 1996
- Staining of fresh, Undecalcified, thin Bone SectionsStain Technology, 1959